Solvias announced the acquisition of Confarma, headquartered in Münchenstein, and its subsidiary Confarma France.
Solvias, a pharmaceutical service provider, is pursuing a long-term growth strategy with the aim of expanding its extensive range of services for pharmaceutical companies. By acquiring the Confarma Group, Solvias and Confarma are increasing the range of analytical services they can offer their partners in pharmaceuticals, biotechnology, and life science.
Valerie Diele-Braun resigned from her position as CEO and member of the Executive Board of IMCD at the end of April for personal reasons.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
Oxea is returning to its old name and its roots.
